EIR Regeneron Pharmaceuticals Aug 2016

Robert Horan FDA$595.00 - Available Now

FDA investigators audited the Regeneron Pharmaceuticals - Rensselaer, NY, United States facility and issued inspectional observation (via FDA 483) on 19 Aug 2016.

Product details

  • Category:
  • Inspection end: 19 Aug 2016
  • Location: Rensselaer, United States
  • FEI: 1000514603
Add To Cart